# FDA Inspection 1269784 - Labcorp Early Development Laboratories, Inc. - May 07, 2025

Source: https://www.keypedia.com/records/fda_inspections/labcorp-early-development-laboratories-inc/03baebe6-56aa-43ed-98d2-19c66733b02b
Source feed: FDA_Inspections

> FDA Inspection 1269784 for Labcorp Early Development Laboratories, Inc. on May 07, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1269784
- Company Name: Labcorp Early Development Laboratories, Inc.
- Inspection Date: 2025-05-07
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Minneapolis District Office

## Related Documents

- [FDA Inspection 1121677 - 2020-02-14](https://www.keypedia.com/records/fda_inspections/labcorp-early-development-laboratories-inc/16c3d88d-4822-420e-9cbc-6ac7a1a07840)
- [FDA Inspection 1065286 - 2018-08-24](https://www.keypedia.com/records/fda_inspections/labcorp-early-development-laboratories-inc/4cb570e4-7e60-489a-950f-42f1d7f100f5)
- [FDA Inspection 808927 - 2012-11-28](https://www.keypedia.com/records/fda_inspections/labcorp-early-development-laboratories-inc/0544b062-92d3-40f6-a42b-0f4909480e6c)
- [FDA Inspection 808927 - 2012-11-28](https://www.keypedia.com/records/fda_inspections/labcorp-early-development-laboratories-inc/3c8ab0af-6bac-401f-a7a8-56748cfc9941)
- [FDA Inspection 740883 - 2011-08-23](https://www.keypedia.com/records/fda_inspections/labcorp-early-development-laboratories-inc/6f73b42f-6fc4-4cb6-b138-7ac80c9acced)

Company: https://www.keypedia.com/companies/labcorp-early-development-laboratories-inc/fd7a8136-483e-4368-bbf9-d12f2e2ca1f2

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d